These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25663530)

  • 1. β-catenin regulates c-Myc and CDKN1A expression in breast cancer cells.
    Xu J; Chen Y; Huo D; Khramtsov A; Khramtsova G; Zhang C; Goss KH; Olopade OI
    Mol Carcinog; 2016 May; 55(5):431-9. PubMed ID: 25663530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
    Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
    Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells.
    Huang WS; Wang JP; Wang T; Fang JY; Lan P; Ma JP
    World J Gastroenterol; 2007 Dec; 13(48):6581-7. PubMed ID: 18161931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental vascular regression is regulated by a Wnt/β-catenin, MYC and CDKN1A pathway that controls cell proliferation and cell death.
    Nayak G; Odaka Y; Prasad V; Solano AF; Yeo EJ; Vemaraju S; Molkentin JD; Trumpp A; Williams B; Rao S; Lang RA
    Development; 2018 Jun; 145(12):. PubMed ID: 29777010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
    Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
    Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
    Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
    Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.
    Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ
    Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
    Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway].
    Du YY; Liu X; Shan BE
    Ai Zheng; 2009 May; 28(5):456-60. PubMed ID: 19624870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
    Lee MF; Hsieh NT; Huang CY; Li CI
    J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
    Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
    Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
    Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
    J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
    Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
    Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression.
    Yochum GS; Cleland R; Goodman RH
    Mol Cell Biol; 2008 Dec; 28(24):7368-79. PubMed ID: 18852287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulindac suppresses beta-catenin expression in human cancer cells.
    Han A; Song Z; Tong C; Hu D; Bi X; Augenlicht LH; Yang W
    Eur J Pharmacol; 2008 Mar; 583(1):26-31. PubMed ID: 18291362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
    Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
    Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription Factor 7-like 2 Mediates Canonical Wnt/β-Catenin Signaling and c-Myc Upregulation in Heart Failure.
    Hou N; Ye B; Li X; Margulies KB; Xu H; Wang X; Li F
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.